BioCryst Pharmaceuticals, Inc. (BCRX)
8.91
-0.19
(-2.09%)
USD |
NASDAQ |
May 29, 16:00
8.92
+0.01
(+0.11%)
Pre-Market: 20:00
BioCryst Pharmaceuticals Total Liabilities (Quarterly) : 1.019B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | 214.90M |
| Taysha Gene Therapies, Inc. | 88.41M |
| Agenus, Inc. | 414.44M |
| Amgen, Inc. | 83.31B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.05M |
| Shareholders Equity (Quarterly) | -553.84M |
| Debt to Equity Ratio | -1.549 |
| Current Ratio | 1.912 |
| Net Debt Paydown Yield | -0.14% |